How Can We Develop More Effective Strategies for Type 2 Diabetes Mellitus Prevention? A Paradigm Shift from a Glucose-Centric to a Beta Cell-Centric Concept of Diabetes

by Yoshifumi Saisho
Published 2018-11-01

SGLT2 Inhibitors: the Star in the Treatment of Type 2 Diabetes?

by Yoshifumi Saisho
Published 2020-05-01

Glycemic Variability and Oxidative Stress: A Link between Diabetes and Cardiovascular Disease?

by Yoshifumi Saisho
Published 2014-10-01

Importance of Beta Cell Function for the Treatment of Type 2 Diabetes

by Yoshifumi Saisho
Published 2014-08-01

Postprandial C-Peptide to Glucose Ratio as a Marker of β Cell Function: Implication for the Management of Type 2 Diabetes

by Yoshifumi Saisho
Published 2016-05-01

Use of Diabetes Treatment Satisfaction Questionnaire in Diabetes Care: Importance of Patient-Reported Outcomes

by Yoshifumi Saisho
Published 2018-05-01

Beta-Cell Mass in Obesity and Type 2 Diabetes, and Its Relation to Pancreas Fat: A Mini-Review

by Jun Inaishi, Yoshifumi Saisho
Published 2020-12-01

Ethnic Similarities and Differences in the Relationship between Beta Cell Mass and Diabetes

by Jun Inaishi, Yoshifumi Saisho
Published 2017-11-01

Management of Dyslipidemia in Type 2 Diabetes: Recent Advances in Nonstatin Treatment

by Kazutoshi Sugiyama, Yoshifumi Saisho
Published 2018-05-01

Correction: Sugiyama, K.; et al. Management of Dyslipidemia in Type 2 Diabetes: Recent Advances in Nonstatin Treatment. Diseases 2018, 6, 44

by Kazutoshi Sugiyama, Yoshifumi Saisho
Published 2018-07-01

Efficacy and safety of switching to insulin glargine 300 U/mL from 100 U/mL in Japanese patients with type 2 diabetes: A 12-month retrospective analysis

by Kazutoshi Sugiyama, Shu Meguro, Yoshifumi Saisho, Junichiro Irie, Masami Tanaka, Hiroshi Itoh
Published 2019-02-01

C-reactive protein, high-molecular-weight adiponectin and development of metabolic syndrome in the Japanese general population: a longitudinal cohort study.

by Yoshifumi Saisho, Hiroshi Hirose, Rachel Roberts, Takayuki Abe, Hiroshi Kawabe, Hiroshi Itoh
Published 2013-01-01

Efficacy and safety of sitagliptin added to insulin in Japanese patients with type 2 diabetes: the EDIT randomized trial.

by Seiji Sato, Yoshifumi Saisho, Kinsei Kou, Shu Meguro, Masami Tanaka, Junichiro Irie, Toshihide Kawai, Hiroshi Itoh
Published 2015-01-01

Relationship between Stage of Diabetic Retinopathy and Pulse Wave Velocity in Japanese Patients with Type 2 Diabetes

by Kumiko Tanaka, Toshihide Kawai, Yoshifumi Saisho, Shu Meguro, Kana Harada, Yuka Satoh, Kaori Kobayashi, Kei Mizushima, Takayuki Abe, Hiroshi Itoh
Published 2013-01-01

Association of glucose tolerance status with pancreatic β‐ and α‐cell mass in community‐based autopsy samples of Japanese individuals: The Hisayama Study

by Jun Inaishi, Yoshifumi Saisho, Yoichiro Hirakawa, Daigo Yoshida, Jun Hata, Naoko Mukai, Yuusuke Watanabe, Yoshinao Oda, Hiroshi Itoh, Toshiharu Ninomiya
Published 2020-09-01

Clinical and genetic characteristics of abnormal glucose tolerance in Japanese women in the first year after gestational diabetes mellitus

by Yoshifumi Kasuga, Kei Miyakoshi, Atsushi Tajima, Yoshifumi Saisho, Satoru Ikenoue, Daigo Ochiai, Tadashi Matsumoto, Naoko Arata, Kenichiro Hata, Mamoru Tanaka
Published 2019-05-01

Usefulness of hemoglobin A1c and glycated albumin measurements for insulinoma screening: an observational case-control study

by Keiichi Torimoto, Yosuke Okada, Yoshiya Tanaka, Atsuko Matsuoka, Yushi Hirota, Wataru Ogawa, Yoshifumi Saisho, Isao Kurihara, Hiroshi Itoh, Shinya Inada, Masafumi Koga
Published 2019-02-01

Past Obesity as well as Present Body Weight Status Is a Risk Factor for Diabetic Nephropathy

by Shu Meguro, Yusuke Kabeya, Karin Tanaka, Toshihide Kawai, Masuomi Tomita, Takeshi Katsuki, Yoichi Oikawa, Yoshihito Atsumi, Akira Shimada, Masami Tanaka, Junichiro Irie, Yoshifumi Saisho, Hiroshi Itoh
Published 2013-01-01

Epigenetic Changes in Neonates Born to Mothers With Gestational Diabetes Mellitus May Be Associated With Neonatal Hypoglycaemia

by Yoshifumi Kasuga, Yoshifumi Kasuga, Tomoko Kawai, Kei Miyakoshi, Yoshifumi Saisho, Masumi Tamagawa, Keita Hasegawa, Keita Hasegawa, Satoru Ikenoue, Daigo Ochiai, Mariko Hida, Mamoru Tanaka, Kenichiro Hata
Published 2021-06-01

Efficacy and safety of once‐weekly exenatide after switching from twice‐daily exenatide in patients with type 2 diabetes

by Yuusuke Watanabe, Yoshifumi Saisho, Jun Inaishi, Kinsei Kou, Akira Yamauchi, Yasuhiko Kanazawa, Yoshiaki Okubo, Mikiya Tokui, Takatoshi Imai, Rie Murakami, Tami Tsuchiya, Hironobu Sasaki, Tatsuhiro Masaoka, Junichiro Irie, Shu Meguro, Hiroshi Itoh, for the Twin‐exenatide Study Group
Published 2020-03-01